Is DaVita HealthCare Partners Inc (DVA) overvalued? · P/E 14, rev $12.82B
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
This page asks whether DaVita HealthCare Partners Inc (DVA) looks expensive on cached numbers — not a short thesis.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
DVA currently screens at market cap $10.77B and trailing P/E 14.1. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next DVA 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the DVA stock page for the full model, not this heading.
Not investment advice.